| Dr John Samuel Banerji, MD, MCH | |
|
100 Hospital Ave, Du Bois, PA 15801-1440 | |
| (814) 371-2200 | |
| Not Available |
| Full Name | Dr John Samuel Banerji |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 24 Years |
| Location | 100 Hospital Ave, Du Bois, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497144562 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | FE60520498 (Washington) | Secondary |
| 208800000X | Urology | MD457337 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Penn Highland Dubois | Dubois, PA | Hospital |
| Penn Highlands Brookville | Brookville, PA | Hospital |
| Penn Highlands Elk | Saint marys, PA | Hospital |
| Upmc Presbyterian Shadyside | Pittsburgh, PA | Hospital |
| Upmc Kane | Kane, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dubois Regional Medical Center | 5890689715 | 349 |
News Archive
A new review addresses the mysteries behind "good" HDL cholesterol and why boosting its levels does not necessarily provide protection from cardiovascular risk for patients. It appears that augmenting the function of HDL cholesterol, rather than its concentration, is key.
The five hospitals of Meridian Health, a System Partner of The Cancer Institute of New Jersey (CINJ), have joined forces with CINJ in offering a clinical research study that examines physical activity patterns and eating habits in colorectal cancer patients who have recently finished treatment.
Pulse cooximeters have long been used to identify and measure the levels of carbon monoxide (CO) in the blood of patients or firefighters.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the rapid uptake and market penetration of key targeted agents, beginning with Roche/Genentech/Chugai's Herceptin, will drive the gastric cancer drug market to more than double, from $700 million in 2009 to nearly $1.5 billion in 2019.
› Verified 8 days ago
| Entity Name | University Of Pittsburgh Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619935004 PECOS PAC ID: 8729990239 Enrollment ID: O20040308000883 |
News Archive
A new review addresses the mysteries behind "good" HDL cholesterol and why boosting its levels does not necessarily provide protection from cardiovascular risk for patients. It appears that augmenting the function of HDL cholesterol, rather than its concentration, is key.
The five hospitals of Meridian Health, a System Partner of The Cancer Institute of New Jersey (CINJ), have joined forces with CINJ in offering a clinical research study that examines physical activity patterns and eating habits in colorectal cancer patients who have recently finished treatment.
Pulse cooximeters have long been used to identify and measure the levels of carbon monoxide (CO) in the blood of patients or firefighters.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the rapid uptake and market penetration of key targeted agents, beginning with Roche/Genentech/Chugai's Herceptin, will drive the gastric cancer drug market to more than double, from $700 million in 2009 to nearly $1.5 billion in 2019.
› Verified 8 days ago
| Entity Name | Dubois Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477657195 PECOS PAC ID: 5890689715 Enrollment ID: O20050329000769 |
News Archive
A new review addresses the mysteries behind "good" HDL cholesterol and why boosting its levels does not necessarily provide protection from cardiovascular risk for patients. It appears that augmenting the function of HDL cholesterol, rather than its concentration, is key.
The five hospitals of Meridian Health, a System Partner of The Cancer Institute of New Jersey (CINJ), have joined forces with CINJ in offering a clinical research study that examines physical activity patterns and eating habits in colorectal cancer patients who have recently finished treatment.
Pulse cooximeters have long been used to identify and measure the levels of carbon monoxide (CO) in the blood of patients or firefighters.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the rapid uptake and market penetration of key targeted agents, beginning with Roche/Genentech/Chugai's Herceptin, will drive the gastric cancer drug market to more than double, from $700 million in 2009 to nearly $1.5 billion in 2019.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Samuel Banerji, MD, MCH 3273 Silver Ridge Ct, Hermitage, PA 16148-6083 Ph: (206) 582-8834 | Dr John Samuel Banerji, MD, MCH 100 Hospital Ave, Du Bois, PA 15801-1440 Ph: (814) 371-2200 |
News Archive
A new review addresses the mysteries behind "good" HDL cholesterol and why boosting its levels does not necessarily provide protection from cardiovascular risk for patients. It appears that augmenting the function of HDL cholesterol, rather than its concentration, is key.
The five hospitals of Meridian Health, a System Partner of The Cancer Institute of New Jersey (CINJ), have joined forces with CINJ in offering a clinical research study that examines physical activity patterns and eating habits in colorectal cancer patients who have recently finished treatment.
Pulse cooximeters have long been used to identify and measure the levels of carbon monoxide (CO) in the blood of patients or firefighters.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the rapid uptake and market penetration of key targeted agents, beginning with Roche/Genentech/Chugai's Herceptin, will drive the gastric cancer drug market to more than double, from $700 million in 2009 to nearly $1.5 billion in 2019.
› Verified 8 days ago
Mr. Indraneel Banerjee, M.D. Urology Medicare: Medicare Enrolled Practice Location: 145 Hospital Ave Ste 200, Du Bois, PA 15801 Phone: 814-375-9200 Fax: 814-375-9080 | |
Assodolah Assadnia, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 145 Hospital Ave, Suite 313, Du Bois, PA 15801 Phone: 814-375-9200 Fax: 814-375-9980 | |
Dr. Joseph E Chang, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 145 Hospital Ave, Suite 200, Du Bois, PA 15801 Phone: 814-375-9200 Fax: 814-375-9980 |